{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:21:58Z","timestamp":1792714918374,"version":"4.5.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T00:00:00Z","timestamp":1652745600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Clin Immunol"],"published-print":{"date-parts":[[2022,8]]},"abstract":"<jats:title>\nAbstract\n<\/jats:title><jats:sec>\n                <jats:title>\nPurpose\n<\/jats:title>\n                <jats:p>Allogeneic hematopoietic stem cell transplant (HSCT) remains the treatment of choice for patients with inborn errors of immunity (IEI). There is little published medical outcome data assessing late medical complications following transition to adult care. We sought to document event-free survival (EFS) in transplanted IEI patients reaching adulthood and describe common late-onset medical complications and factors influencing EFS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>In this landmark analysis, 83 adults surviving 5\u00a0years or more following prior HSCT in childhood for IEI were recruited. The primary endpoint was event-free survival, defined as time post-first HSCT to graft failure, graft rejection, chronic infection, life-threatening or recurrent infections, malignancy, significant autoimmune disease, moderate to severe GVHD or major organ dysfunction. All events occurring less than 5\u00a0years post-HSCT were excluded.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>EFS was 51% for the whole cohort at a median of 20\u00a0years post HSCT. Multivariable analysis identified age at transplant and whole blood chimerism as independent predictors of long-term EFS. Year of HSCT, donor, conditioning intensity and underlying diagnosis had no significant impact on EFS. 59 events occurring beyond 5\u00a0years post-HSCT were documented in 37 patients (45% cohort). A total of 25 patients (30% cohort) experienced ongoing significant complications requiring active medical intervention at last follow-up.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Although most patients achieved excellent, durable immune reconstitution with infrequent transplant-related complications, very late complications are common and associated with mixed chimerism post-HSCT. Early intervention to correct mixed chimerism may improve long-term outcomes and adult health following HSCT for IEI in childhood.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10875-022-01278-6","type":"journal-article","created":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T13:03:41Z","timestamp":1652792621000},"page":"1230-1243","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":21,"title":["Retrospective, Landmark Analysis of Long-term Adult Morbidity Following Allogeneic HSCT for Inborn Errors of Immunity in Infancy and Childhood"],"prefix":"10.1007","volume":"42","author":[{"given":"James W.","family":"Day","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reem","family":"Elfeky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethany","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupert","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austen","family":"Worth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Veys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Carpenter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachael","family":"Hough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Titman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ridout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Workman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Hernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit","family":"Sandford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arian","family":"Laurence","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan O.","family":"Burns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4834-1130","authenticated-orcid":false,"given":"Emma C.","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,5,17]]},"reference":[{"issue":"5","key":"1278_CR1","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1056\/NEJMoa1401177","volume":"371","author":"SY Pai","year":"2014","unstructured":"Pai SY, Logan BR, Griffith LM, Buckley RH, Parrott RE, Dvorak CC, et al. Transplantation outcomes for severe combined immunodeficiency, 2000\u20132009. N Engl J Med. 2014;371(5):434\u201346.","journal-title":"N Engl J Med"},{"issue":"25","key":"1278_CR2","doi-asserted-by":"publisher","first-page":"2718","DOI":"10.1182\/blood-2017-05-781849","volume":"130","author":"J Heimall","year":"2017","unstructured":"Heimall J, Logan BR, Cowan MJ, Notarangelo LD, Griffith LM, Puck JM, et al. Immune reconstitution and survival of 100 SCID patients post-hematopoietic cell transplant: a IEITC natural history study. Blood. 2017;130(25):2718\u201327.","journal-title":"Blood"},{"key":"1278_CR3","doi-asserted-by":"crossref","unstructured":"Chiesa R, Wang J, Blok HJ, Hazelaar S, Neven B, Moshous D, et al. Haematopoietic Cell Transplantation in Chronic Granulomatous Disease: a Study on 712 Children and Adults. Blood. 2020.","DOI":"10.1182\/blood.2020005590"},{"issue":"6","key":"1278_CR4","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1182\/blood-2010-11-319376","volume":"118","author":"D Moratto","year":"2011","unstructured":"Moratto D, Giliani S, Bonfim C, Mazzolari E, Fischer A, Ochs HD, et al. Long-term outcome and lineage-specific chimerism in 194 patients with Wiskott-Aldrich syndrome treated by hematopoietic cell transplantation in the period 1980\u20132009: an international collaborative study. Blood. 2011;118(6):1675\u201384.","journal-title":"Blood"},{"issue":"9","key":"1278_CR5","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.1182\/blood-2012-08-448118","volume":"121","author":"N Mahlaoui","year":"2013","unstructured":"Mahlaoui N, Pellier I, Mignot C, Jais JP, Bilhou-Nab\u00e9ra C, Moshous D, et al. Characteristics and outcome of early-onset, severe forms of Wiskott-Aldrich syndrome. Blood. 2013;121(9):1510\u20136.","journal-title":"Blood"},{"issue":"10","key":"1278_CR6","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1182\/blood.2020007891","volume":"136","author":"EC Morris","year":"2020","unstructured":"Morris EC. HSCT for CGD? Yes, and the sooner the better. Blood. 2020;136(10):1121\u20133.","journal-title":"Blood"},{"issue":"4","key":"1278_CR7","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/j.jaci.2014.06.021","volume":"134","author":"CC Dvorak","year":"2014","unstructured":"Dvorak CC, Hassan A, Slatter MA, H\u00f6nig M, Lankester AC, Buckley RH, et al. Comparison of outcomes of hematopoietic stem cell transplantation without chemotherapy conditioning by using matched sibling and unrelated donors for treatment of severe combined immunodeficiency. J Allergy Clin Immunol. 2014;134(4):935-43.e15.","journal-title":"J Allergy Clin Immunol"},{"issue":"17","key":"1278_CR8","doi-asserted-by":"publisher","first-page":"1737","DOI":"10.1182\/blood-2018-03-840702","volume":"132","author":"E Haddad","year":"2018","unstructured":"Haddad E, Logan BR, Griffith LM, Buckley RH, Parrott RE, Prockop SE, et al. SCID genotype and 6-month posttransplant CD4 count predict survival and immune recovery. Blood. 2018;132(17):1737\u201349.","journal-title":"Blood"},{"issue":"2","key":"1278_CR9","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1182\/blood-2013-01-476432","volume":"123","author":"C Schuetz","year":"2014","unstructured":"Schuetz C, Neven B, Dvorak CC, Leroy S, Ege MJ, Pannicke U, et al. SCID patients with ARTEMIS vs RAG deficiencies following HCT: increased risk of late toxicity in ARTEMIS-deficient SCID. Blood. 2014;123(2):281\u20139.","journal-title":"Blood"},{"issue":"15","key":"1278_CR10","doi-asserted-by":"publisher","first-page":"2198","DOI":"10.1182\/blood-2016-11-748616","volume":"129","author":"IJ Abd Hamid","year":"2017","unstructured":"Abd Hamid IJ, Slatter MA, McKendrick F, Pearce MS, Gennery AR. Long-term outcome of hematopoietic stem cell transplantation for IL2RG\/JAK3 SCID: a cohort report. Blood. 2017;129(15):2198\u2013201.","journal-title":"Blood"},{"issue":"10","key":"1278_CR11","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/bmt.2014.106","volume":"49","author":"E Das-Gupta","year":"2014","unstructured":"Das-Gupta E, Dignan F, Shaw B, Raj K, Malladi R, Gennery A, et al. Extracorporeal photopheresis for treatment of adults and children with acute GVHD: UK consensus statement and review of published literature. Bone Marrow Transplant. 2014;49(10):1251\u20138.","journal-title":"Bone Marrow Transplant"},{"issue":"9915","key":"1278_CR12","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/S0140-6736(13)62069-3","volume":"383","author":"T Gungor","year":"2014","unstructured":"Gungor T, Teira P, Slatter M, Stussi G, Stepensky P, Moshous D, et al. Reduced-intensity conditioning and HLA-matched haemopoietic stem-cell transplantation in patients with chronic granulomatous disease: a prospective multicentre study. Lancet. 2014;383(9915):436\u201348.","journal-title":"Lancet"},{"issue":"16","key":"1278_CR13","doi-asserted-by":"publisher","first-page":"4367","DOI":"10.1182\/blood-2010-10-312082","volume":"117","author":"MA Slatter","year":"2011","unstructured":"Slatter MA, Rao K, Amrolia P, Flood T, Abinun M, Hambleton S, et al. Treosulfan-based conditioning regimens for hematopoietic stem cell transplantation in children with primary immunodeficiency: United Kingdom experience. Blood. 2011;117(16):4367\u201375.","journal-title":"Blood"},{"issue":"4","key":"1278_CR14","doi-asserted-by":"publisher","first-page":"1417","DOI":"10.1016\/j.jaci.2017.07.008","volume":"141","author":"RM Shah","year":"2018","unstructured":"Shah RM, Elfeky R, Nademi Z, Qasim W, Amrolia P, Chiesa R, et al. T-cell receptor \u03b1\u03b2 and CD19 + Cell-Depleted Haploidentical and Mismatched Hematopoietic Stem Cell Transplantation in Primary Immune Deficiency. J Allergy Clin Immunol. 2018;141(4):1417-26.e1.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"1278_CR15","doi-asserted-by":"publisher","first-page":"288","DOI":"10.1016\/j.bbmt.2014.10.010","volume":"21","author":"HL Haines","year":"2015","unstructured":"Haines HL, Bleesing JJ, Davies SM, Hornung L, Jordan MB, Marsh RA, et al. Outcomes of donor lymphocyte infusion for treatment of mixed donor chimerism after a reduced-intensity preparative regimen for pediatric patients with nonmalignant diseases. Biol Blood Marrow Transplant. 2015;21(2):288\u201392.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"6","key":"1278_CR16","doi-asserted-by":"publisher","first-page":"949","DOI":"10.1016\/j.bbmt.2013.03.001","volume":"19","author":"M Bar","year":"2013","unstructured":"Bar M, Sandmaier BM, Inamoto Y, et al. Donor lymphocyte infusion for relapsed hematological malignancies after allogeneic hematopoietic cell transplantation: prognostic relevance of the initial CD3+ T cell dose. Biol Blood Marrow Transplant. 2013;19(6):949\u201357.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"1278_CR17","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1038\/bmt.2008.321","volume":"43","author":"DA Rizzieri","year":"2009","unstructured":"Rizzieri DA, Dev P, Long GD, et al. Response and toxicity of donor lymphocyte infusions following T-cell depleted non-myeloablative allogeneic hematopoietic SCT from 3\u20136\/6 HLA matched donors. Bone Marrow Transplant. 2009;43(4):327\u201333.","journal-title":"Bone Marrow Transplant"},{"issue":"9","key":"1278_CR18","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.1182\/blood-2002-07-2231","volume":"101","author":"G Soci\u00e9","year":"2003","unstructured":"Soci\u00e9 G, Salooja N, Cohen A, Rovelli A, Carreras E, Locasciulli A, et al. Nonmalignant late effects after allogeneic stem cell transplantation. Blood. 2003;101(9):3373\u201385.","journal-title":"Blood"},{"key":"1278_CR19","doi-asserted-by":"crossref","unstructured":"Gennery AR, Lankester A, (EBMT) IEWPIotESfBaMT. Long Term Outcome and Immune Function After Hematopoietic Stem Cell Transplantation for Primary Immunodeficiency. Front Pediatr. 2019;7:381.","DOI":"10.3389\/fped.2019.00381"},{"issue":"5","key":"1278_CR20","doi-asserted-by":"publisher","first-page":"1306","DOI":"10.1016\/j.jaci.2013.03.014","volume":"131","author":"B Horn","year":"2013","unstructured":"Horn B, Cowan MJ. Unresolved issues in hematopoietic stem cell transplantation for severe combined immunodeficiency: need for safer conditioning and reduced late effects. J Allergy Clin Immunol. 2013;131(5):1306\u201311.","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"1278_CR21","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.jaci.2007.08.007","volume":"120","author":"E Mazzolari","year":"2007","unstructured":"Mazzolari E, Forino C, Guerci S, Imberti L, Lanfranchi A, Porta F, et al. Long-term immune reconstitution and clinical outcome after stem cell transplantation for severe T-cell immunodeficiency. J Allergy Clin Immunol. 2007;120(4):892\u20139.","journal-title":"J Allergy Clin Immunol"},{"key":"1278_CR22","doi-asserted-by":"crossref","unstructured":"Heimall J, Puck J, Buckley R, Fleisher TA, Gennery AR, Neven B, et al. Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant Consortium International Conference on Late Effects after Pediatric HCT. Biol Blood Marrow Transplant. 2017;23(3):379\u201387.","DOI":"10.1016\/j.bbmt.2016.12.619"},{"issue":"8","key":"1278_CR23","doi-asserted-by":"publisher","first-page":"3595","DOI":"10.1182\/blood-2006-07-034678","volume":"109","author":"M H\u00f6nig","year":"2007","unstructured":"H\u00f6nig M, Albert MH, Schulz A, Sparber-Sauer M, Sch\u00fctz C, Belohradsky B, et al. Patients with adenosine deaminase deficiency surviving after hematopoietic stem cell transplantation are at high risk of CNS complications. Blood. 2007;109(8):3595\u2013602.","journal-title":"Blood"},{"issue":"9","key":"1278_CR24","doi-asserted-by":"publisher","first-page":"1438","DOI":"10.1016\/j.bbmt.2012.03.003","volume":"18","author":"M Eapen","year":"2012","unstructured":"Eapen M, Ahn KW, Orchard PJ, Cowan MJ, Davies SM, Fasth A, et al. Long-term survival and late deaths after hematopoietic cell transplantation for primary immunodeficiency diseases and inborn errors of metabolism. Biol Blood Marrow Transplant. 2012;18(9):1438\u201345.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"17","key":"1278_CR25","doi-asserted-by":"publisher","first-page":"4114","DOI":"10.1182\/blood-2008-09-177923","volume":"113","author":"B Neven","year":"2009","unstructured":"Neven B, Leroy S, Decaluwe H, Le Deist F, Picard C, Moshous D, et al. Long-term outcome after hematopoietic stem cell transplantation of a single-center cohort of 90 patients with severe combined immunodeficiency. Blood. 2009;113(17):4114\u201324.","journal-title":"Blood"},{"issue":"1","key":"1278_CR26","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1007\/s10875-020-00758-x","volume":"40","author":"A Bousfiha","year":"2020","unstructured":"Bousfiha A, Jeddane L, Picard C, et al. Human Inborn Errors of Immunity: 2019 Update of the IUIS Phenotypical Classification. J Clin Immunol. 2020;40(1):66\u201381.","journal-title":"J Clin Immunol"},{"key":"1278_CR27","doi-asserted-by":"crossref","unstructured":"Filipovich AH, Weisdorf D, Pavletic S, et al. National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant. 2005;11(12):945\u2013956.","DOI":"10.1016\/j.bbmt.2005.10.001"},{"issue":"8","key":"1278_CR28","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.1182\/blood.V95.8.2659","volume":"95","author":"J Serrano","year":"2000","unstructured":"Serrano J, Roman J, Sanchez J, Jimenez A, Castillejo JA, Herrera C, et al. Molecular analysis of lineage-specific chimerism and minimal residual disease by RT-PCR of p210(BCR-ABL) and p190(BCR-ABL) after allogeneic bone marrow transplantation for chronic myeloid leukemia: increasing mixed myeloid chimerism and p190(BCR-ABL) detection precede cytogenetic relapse. Blood. 2000;95(8):2659\u201365.","journal-title":"Blood"},{"issue":"12","key":"1278_CR29","doi-asserted-by":"publisher","first-page":"2079","DOI":"10.1038\/sj.leu.2401581","volume":"13","author":"P Bader","year":"1999","unstructured":"Bader P, Klingebiel T, Schaudt A, Theurer-Mainka U, Handgretinger R, Lang P, et al. Prevention of relapse in pediatric patients with acute leukemias and MDS after allogeneic SCT by early immunotherapy initiated on the basis of increasing mixed chimerism: a single center experience of 12 children. Leukemia. 1999;13(12):2079\u201386.","journal-title":"Leukemia"},{"issue":"2","key":"1278_CR30","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1001\/jamaoncol.2018.4934","volume":"5","author":"A Tichelli","year":"2019","unstructured":"Tichelli A, Beohou E, Labopin M, et al. Evaluation of Second Solid Cancers After Hematopoietic Stem Cell Transplantation in European Patients. JAMA Oncol. 2019;5(2):229\u201335.","journal-title":"JAMA Oncol"},{"issue":"9","key":"1278_CR31","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1182\/bloodadvances.2020001748","volume":"4","author":"M Felber","year":"2020","unstructured":"Felber M, Steward CG, Kentouche K, et al. Targeted busulfan-based reduced-intensity conditioning and HLA-matched HSCT cure hemophagocytic lymphohistiocytosis. Blood Adv. 2020;4(9):1998\u20132010.","journal-title":"Blood Adv"},{"key":"1278_CR32","doi-asserted-by":"crossref","unstructured":"Admiraal R, van Kesteren C, Jol-van der Zijde CM, et al. Association between anti-thymocyte globulin exposure and CD4+ immune reconstitution in paediatric haemopoietic cell transplantation: a multicentre, retrospective pharmacodynamic cohort analysis. Lancet Haematol. 2015;2(5):e194-e203.","DOI":"10.1016\/S2352-3026(15)00045-9"}],"container-title":["Journal of Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10875-022-01278-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10875-022-01278-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,6]],"date-time":"2022-10-06T17:46:46Z","timestamp":1665078406000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10875-022-01278-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,17]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["1278"],"URL":"https:\/\/doi.org\/10.1007\/s10875-022-01278-6","relation":{},"ISSN":["0271-9142","1573-2592"],"issn-type":[{"value":"0271-9142","type":"print"},{"value":"1573-2592","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,17]]},"assertion":[{"value":"21 December 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 May 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics Approval"}},{"value":"All patients provided written informed consent as per institutional guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All patients provided written informed consent as per institutional guidelines.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"None declared.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of Interest\/Competing Interests"}}]}}